About OphtAI
OphtAI is a French healthcare AI company specializing in artificial intelligence for ophthalmology. It was formed as a joint venture between Evolucare, a key player in hospital IT systems, and ADCIS, an expert in image analysis. The company’s solutions are designed to assist ophthalmology professionals in addressing the increasing demands of patient care, including a wider range of activities and diseases, and a growing number of patients requiring follow-up, care, or screening. OphtAI’s technology aims to optimize organizational workflows and enhance diagnostic performance, allowing specialists to focus on complex cases and high-value activities while ensuring widespread and safe screening.
For physicians, OphtAI offers a CE-marked medical device that provides semi-automated screening and grading of various retinal pathologies. The AI analyzes retinal images to detect conditions such as diabetic retinopathy (DR), diabetic macular edema, glaucoma, and age-related macular degeneration (AMD). The system provides rapid, computer-aided diagnoses with explicable results through lesion mapping and confidence indexes. It also includes features like real-time image quality checks to avoid re-examinations, automated preliminary patient sorting based on criticality, and automated patient record filling. OphtAI’s solutions are compatible with standard field color retinographs and can be integrated into existing IT tools and teleophthalmology platforms, facilitating collaboration among healthcare professionals and streamlining workflows. The company emphasizes that its AI does not replace clinicians but enhances their capabilities, reducing the risk of error, identifying early warning signs, and improving clinical decision-making.
Focus Areas
Business Intelligence
| Technology | Cloud-native (Microsoft Azure), Deep Learning, AI operating system (integrated with various fundus cameras and ophthalmology software) |
What Physicians Need to Know
OphtAI's AI-powered retinal image analysis offers ophthalmologists and other eye care professionals a powerful tool to enhance diagnostic accuracy, improve screening efficiency, and optimize patient management. The system's high sensitivity and rapid analysis can aid in early detection of critical pathologies like Diabetic Retinopathy, Glaucoma, and AMD, allowing for timely intervention and potentially preventing vision loss. Its ability to provide detailed reports with lesion localization and confidence scores can support clinical decision-making. Furthermore, the tele-ophthalmology capabilities and integration options can help extend screening reach, particularly in underserved areas, and streamline workflows by automating initial image review and patient prioritization. This allows specialists to focus on complex cases and higher-value activities, ultimately improving the overall quality and accessibility of eye care. It's important to remember that AI is a tool to augment, not replace, clinical expertise.
OphtAI offers flexible integration options, including a web-based platform (OphtAI WEB), a desktop application (OphtAI APP), and an API for seamless integration into partners' software offerings. They are compatible with standard field color retinographs and have established partnerships for integration with various ophthalmology software and data management platforms like Topcon Harmony, Icare, CrystalVue, Area, Oplus, Optomed, Teo, and UmamiView. This allows for automated analysis of photos added to a PC directory and the automatic generation of PDF reports, directly within existing clinical workflows.
What the Web Says
OphtAI is a company that develops AI-powered solutions for the early detection and screening of eye pathologies, such as Diabetic Retinopathy, glaucoma, and Age-related Macular Degeneration (AMD). Their technology aims to provide rapid and accurate analysis of retinal images, often outperforming human screeners in sensitivity. The company's solutions are available as a standalone web product or as an embedded solution in fundus cameras, and they are working towards FDA approval for their products in the US market.
Overall: PositiveStrengths
- High sensitivity and specificity in detecting eye pathologies.
- Faster image processing compared to other solutions.
- Potential to reduce screening costs.
- Backed by clinical specialists and scientific laboratories.
- Aims to make AI accessible and easy to use in ophthalmological practice.
- Capable of detecting multiple retinal pathologies.
Limitations
- Limited public product reviews available on major platforms like G2, Glassdoor, and Capterra.
- No specific employer reviews found for OphtAI directly.
- General Reddit discussions about AI in ophthalmology suggest current AI tools may not be suitable for complex subspecialty discussions or nuanced imaging.
Based on reviews from: Google Search, Reddit, Evolucare, OphtAI website
Last updated: 2026-09-20
Videos
News, demos, and interviews about OphtAI.
Videos load interactively. If none appear, search YouTube for OphtAI →
Press & Coverage
Frequently Asked Questions
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]